Skip to main content
966 Suchergebnisse für:

Trichomonas vaginalis 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. Open Access 01.02.2024 | OriginalPaper

    Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countries

    In 2021, the World Health Organization (WHO) estimated that over 367 million people aged 15 to 49 globally were infected each year with one of three curable sexually transmitted infections (STIs): Chlamydia trachomatis (CT), 128 million; Neisseria …

  2. Open Access 01.02.2024 | OriginalPaper

    Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa

    Globally, the incidence of sexually transmitted infections (STI) continues to present major contemporary health challenges. STIs can be caused by a range (up to 30 species) of bacterial, parasitic or viral pathogens. In 2020, three common …

  3. 02.11.2023 | BriefCommunication

    Detection of Trichomonas vaginalis by Allplex™ STI Essential Assay (Seegene) in clinical samples from the Brazilian public health system users

    The failures in Trichomonas vaginalis (TV) infection diagnosis leave more than half of cases unidentified. In this report, urine and vaginal discharge samples were analyzed by wet mount, culture examination, and real-time PCR by Allplex™ …

  4. Open Access 01.12.2023 | OriginalPaper

    The correlation between Trichomonas vaginalis infection and reproductive system cancer: a systematic review and meta-analysis

    Trichomoniasis is the most common non-viral sexually transmitted infection (STI) in human beings which is responsible for a range of symptoms such as increasing vaginal secretion, pruritus and irritation of perineum in female [ 1 ]. According to …

  5. Open Access 01.12.2023 | OriginalPaper

    Association between red blood cell folate and Trichomonas vaginalis infection among women

    The pathology of Trichomoniasis is due to the damage to host epithelial cells by various processes during the infection, and its clinical manifestations also vary between men and women. 50 percent of women infected with Trichomonas vaginalis

  6. Open Access 01.12.2023 | OriginalPaper

    Molecular diagnosis of Trichomonas vaginalis in liquid-based Papanicolaou samples in Shiraz, southern Iran

    Trichomoniasis is caused by the protozoan Trichomonas vaginalis , which is one of the most common sexually transmitted diseases (STD), with an estimated annual incidence of 276.4 million cases globally [ 1 , 2 ]. In women, the cervix, vagina …

  7. Open Access 11.11.2022 | OriginalPaper

    The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay

    Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) can lead to long-term sequelae in males and females; however, global prevalence data vary between geographical regions, as these sexually transmitted infections are not included in routine …

  8. 17.05.2022 | OriginalPaper

    Molecular typing of the actin gene of Trichomonas vaginalis isolates in Tehran, Iran

    Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis with worldwide distribution. This study evaluated actin genotypes of T. vaginalis isolates using PCR–RFLP and sequence analysis in Tehran, Iran. Overall, 850 vaginal samples …

  9. 23.04.2022 | OriginalPaper

    Induction of apoptosis by hydroalcoholic and methanolic extract of Deracocephalum kotschyi on Trichomonas vaginalis

    Trichomonas vaginalis (T.vaginalis) causes trichomoniasis, a sexually transmitted infection. Dracocephalum kotschyi (D. kotschyi) belongs to the family of Labiatae. Its antispasmodic and analgesic properties are well known in Iran. This work aimed …

  10. Open Access 01.12.2021 | OriginalPaper

    Antibacterial and anti-Trichomonas Vaginalis effects of Rosa Damascena mill petal oil (a persian medicine product), aqueous and hydroalcoholic extracts

    Infectious diseases represent a serious health problem today and account for one-third of all deaths worldwide. Antimicrobials of plant origin have enormous therapeutic potential, as they are effective in the treatment of infectious diseases while …

  11. Open Access 01.12.2021 | OriginalPaper

    Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017

    Trichomonas vaginalis (T. vaginalis) is the most common, curable parasitic sexually transmitted infection (STI) worldwide affecting both men and women [ 1 ]. In 2012, 143 million cases of T. vaginalis had been diagnosed in women aged 15–49 years …

  12. Open Access 01.12.2021 | OriginalPaper

    Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes

    In the Netherlands, pregnant women are screened for HIV, syphilis and hepatitis B [ 1 , 2 ], but not for other sexually transmitted infections (STI). Hence, limited data are available on STI such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae … (NG) or

  13. 13.03.2021 | OriginalPaper

    Anti-parasitic activity of nano Citrullus colocynthis and nano Capparis spinose against Trichomonas vaginalis in vitro

    The use of plant extracts and the benefit of their unique properties in treating various pathogens is the return to mother nature, and an attempt to overcome the problems of side effects resulting from the use of chemical drugs and the ability of …

  14. Open Access 01.12.2021 | OriginalPaper

    Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil

    Sexually transmitted infections (STIs) represent a significant public issue that affects people`s health worldwide. [ 1 ]. In 2016, an estimation of 376 million new infections (more than 1 million per day) was reported in people aged between 15 and …

  15. 07.10.2020 | OriginalPaper

    Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands

    Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) are pathogens responsible for a variety of sexually transmitted infections (STIs) which can be symptomatic as well as asymptomatic. In …

  16. Open Access 01.12.2020 | OriginalPaper

    Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2–3 among HPV16 positive female: a large population-based study

    Cervical cancer is a common malignant tumor of the female reproductive system, and it progresses rapidly with a high mortality rate [ 1 ]. HPV is a DNA virus, which is widely found in nature. Hr-HPV (e.g. HPV 16, 18, 31, 35, 39, 45, 51, 52, 56, 58 …

  17. Open Access 01.12.2020 | OriginalPaper

    Development of a convenient detection method for Trichomonas vaginalis based on loop-mediated isothermal amplification targeting adhesion protein 65

    Trichomoniasis, which is resulting from T. vaginalis, a kind of protozoa with flagella, has been considered as a commonly seen curable disease with the transmission approach of sex and the quantity of affected people all around the world reaches …

  18. 01.03.2020 | OriginalPaper

    The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors

    Treatment with fludarabine phosphate (9-β-D-arabinofuranosyl-2-F-adenine 5′-phosphate, F-araAMP) leads to regressions and cures of human tumor xenografts that express Escherichia coli purine nucleoside phosphorylase (EcPNP). This occurs despite …

  19. Open Access 08.02.2020 | OriginalPaper

    Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia

    The large majority of studies investigating associations between bacterial vaginosis (BV) and sexually transmitted infections (STIs) have been conducted among predominantly young women with high risk for STIs. Since a risky sexual behavior is a …

  20. 08.11.2019 | OriginalPaper

    Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study

    The purpose was to evaluate whether probiotics can increase the effectiveness of antimicrobial therapy. Ninety women with Trichomonas vaginalis (TV) in the presence BV were included in the study of regimens for therapy combination with …

Suchergebnisse filtern:

e.Medpedia

Sexuell übertragbare Erkrankungen: Grundlagen

Braun-Falco's Dermatologie, Venerologie und Allergologie
Infektiöse Erkrankungen, die vorwiegend durch sexuelle Kontakte übertragen werden, sind zur Gruppe der sexuell übertragbaren Infektionen zusammengefasst worden. Sexually transmitted infections (STI) hat die Bezeichnung sexually transmitted diseases (STD) abgelöst, da Infektionen häufig asymptomatisch verlaufen, (beispielsweise mit Chlamydien, Gonokokken oder humanen Papillomviren). Die Lehre von den sexuell übertragbaren Erkrankungen oder Geschlechtskrankheiten wird als Venerologie (Venus = römische Liebesgöttin) bezeichnet und wird durch die Doppelbezeichnung des Fachs Dermatologie und Venerologie manifest. Die Abgrenzung des breiten Spektrums genitoanaler Hautkrankheiten von STI-Manifestationen in gleicher Lokalisation, aber auch in der Mundhöhle und am restlichen Integument, besitzt für das Fachgebiet Dermatologie größte Bedeutung.

weitere e.Medpedia Einträge

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.